Newstar Injectors Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
- Paid Up Capital ₹ 2.10 Cr
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.79 Cr
- Revenue Growth 53.01%
- Profit Growth 37.14%
- Ebitda 47.29%
- Net Worth -81.60%
- Total Assets -1.92%
About Newstar Injectors
Newstar Injectors Private Limited (NIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 September 2016 (Eight years and four months 30 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 2.10 Cr.
The company currently has active open charges totaling ₹5.79 Cr.
Srinivasan Ganesan and Lekha Srinivasan serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2016PTC112524
-
Company No.
112524
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Sep 2016
-
Date of AGM
28 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Newstar Injectors?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasan Ganesan
|
Director | 15-Sep-2016 | Current |
|
Lekha Srinivasan
|
Director | 15-Sep-2016 | Current |
Financial Performance of Newstar Injectors.
Newstar Injectors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.01% increase. The company also saw a substantial improvement in profitability, with a 37.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 81.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Newstar Injectors?
Unlock access to Newstar Injectors's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.79 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 5.79 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2021 | Others | ₹2.40 M | Open |
| 26 Mar 2021 | Others | ₹1.99 M | Open |
| 28 Dec 2020 | Others | ₹6.55 M | Open |
| 19 Oct 2020 | Others | ₹5.20 M | Open |
| 19 May 2020 | Others | ₹2.50 M | Open |
How Many Employees Work at Newstar Injectors?
Newstar Injectors has a workforce of 14 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Newstar Injectors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newstar Injectors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.